Cleared Traditional

K231378 - Exablate Model 2100V1, Exablate Prostate System, Exablate MRgFUS, Exablate 2100V1 Type 3.0 (FDA 510(k) Clearance)

Oct 2023
Decision
171d
Days
Class 2
Risk

K231378 is an FDA 510(k) clearance for the Exablate Model 2100V1, Exablate Prostate System, Exablate MRgFUS, Exablate 2100V1 Type 3.0. This device is classified as a High Intensity Ultrasound System For Prostate Tissue Ablation (Class II - Special Controls, product code PLP).

Submitted by Insightec , Ltd. (Tirat-Hacarmet, IL). The FDA issued a Cleared decision on October 30, 2023, 171 days after receiving the submission on May 12, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.4340. Prostate Tissue Ablation.

Submission Details

510(k) Number K231378 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 12, 2023
Decision Date October 30, 2023
Days to Decision 171 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PLP - High Intensity Ultrasound System For Prostate Tissue Ablation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.4340
Definition Prostate Tissue Ablation